For research use only. Not for human consumption. Affiliate links may earn commissions. Not medical advice.

Tirzepatide is a first-in-class 39-amino acid dual GIP/GLP-1 receptor agonist featuring a C20 fatty diacid modification that enables extended half-life, studied extensively for glycemic control and metabolic research applications.
Compare suppliers below for purity, pricing, and availability from vetted research vendors.
No variants or suppliers have been added yet.
COA / Third-Party Testing
Vetted suppliers provide third-party Certificates of Analysis (COAs). Always verify COAs independently on the supplier's website before purchasing.
We aggregate vetted research suppliers for transparency. Always verify COAs independently.
Affiliate Disclosure: Links on this page may be affiliate links. We may earn a commission at no extra cost to you.